Microdosing GLP-1 Receptor Agonists During Perimenopause: A Clinical Approach to Hormonal Weight Gain Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC Perimenopause represents a challenging time for women, with up to 70% experiencing weight gain due to declining estrogen levels, decreased energy expenditure, and metabolic changes
Potential Cost Savings Brand-name weight loss medications can be expensive, with some GLP-1 receptor agonists costing hundreds (or even thousands) of dollars per month
The appetite suppression fades , food noise returns, and caloric intake gradually increases
AUD, notes the Mayo Clinic, is a pattern of alcohol use that involves problems controlling your drinking, being preoccupied with alcohol or continuing to use alcohol even when it causes problems